Capstone Therapeutics's total assets for Q3 2025 were $58.48M, an increase of 12.72% from the previous quarter. CAPS total liabilities were $31.33M for the fiscal quarter, a 22.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.